Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-19

Clinical Trial Update: Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of azilsartan medoxomil co-administered with chlorthalidone in adults with essential hypertension. Results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorthalidone (chlorthalidone)
  • Edarbi (azilsartan medoxomil)

Snippet

Sponsor: Takeda | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2011-04-19